Editorials

Metabolomics in Cancer

Abstract

Metabolomics in Cancer
1. Andre A, Mekoba B, Muideen A, Moore C. Oncologic Emergencies: Hypercalcemia of Malignancy and Tumor Lysis Syndrome. US Pharm. 2015;40(5):3-7.
2. Madeddu C, Maccio A, Mantovani G. Metabolic Changes in Cancer Patients. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: 2011;10(4)
3. Wang L, Liu X, Yang Q. Application of Metabolomics in Cancer Research: As a Powerful Tool to Screen Biomarker for Diagnosis, Monitoring and Prognosis of Cancer. Biomarkers Journal. 2018, doi: 10.21767/2472-1646.100050.
4. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2013 Jul 25;499(7459):504.
5. Yusof HM, Ab-Rahim S, Suddin LS, Saman MSA, Mazlan M. Metabolomics Profiling on Different Stages of Colorectal Cancer: A Systematic Review.Malays J Med Sci. 2018 Sep;25(5):16-34.
6. Jinping Gu,Yaqing Xiao,Dan Shu,Xianrui Liang,Xiaomin Hu,YuanyuanXie et al.Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by 1H-NMR Spectrometry. Dis Markers.2019: 3491852.
Files
IssueVol 11 No 2 (2019) QRcode
SectionEditorials
DOI https://doi.org/10.18502/bccr.v11i2.1654
Keywords
No Keyword

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mobasheri M. Metabolomics in Cancer. Basic Clin Cancer Res. 2019;11(2):82-83.